View Cart (0 items)

Pharmaceutical

Johnson & Johnson to Settle Criminal Charge over Risperdal

The Associated Press reports that Johnson & Johnson has tentatively agreed to settle a single misdemeanor criminal charge related to a multi-year government investigation into the marketing of its psychiatric
Read More

Affymax Receives $10 Million Milestone Payment from Takeda

Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt;
Read More

Pfizer Global Drug Sales Fall

Pfizer showed further weakness in its main business of prescription medicines, sending shares down more than 3 percent on concern over future growth as the company prepares to divest better-performing
Read More

Merck to Cut 13,000 Jobs

According to Reuters, Merck & Co. plans to cut another 12,000 to 13,000 jobs by late 2015 to wring out additional annual cost savings of up to $1.5 billion that
Read More

Bristol-Myers Profit Falls but Sales Jump 14 Percent

The Associated Press reports that Bristol-Myers Squibb Co. said its second-quarter profit fell nearly 3 percent due to higher taxes and increased costs for production, marketing and administration. Those were
Read More

Class Action Lawsuit Filed Against Novo Nordisk

A class action lawsuit has been filed against pharmaceutical company Novo Nordisk on of behalf drug sales reps for alleged overtime wage and hour violations. According to the wage
Read More

Raptor Pharmaceutical Drug Meets Goal in Clinical Trial

Shares of Raptor Pharmaceutical Corp. retreated from annual highs Monday after the company said its most advanced drug candidate met its main goal in a late-stage clinical trial, according to
Read More

GlaxoSmithKline-Pfizer AIDS Pill May Surpass Bristol’s

According to Bloomberg, a drug developed by GlaxoSmithKline and Pfizer controlled HIV faster and more safely than Bristol-Myers Squibb’s Sustiva in a study, suggesting the experimental medicine may one day
Read More

Teva Completes Acquisition of Third Largest Generics Company in Japan

Business Wire reports that Teva Pharmaceutical Industries Ltd. has completed the acquisition of Taiyo Pharmaceutical Industry Co. Ltd. for $934 million in cash. Taiyo is the third largest generics manufacturer
Read More

Johnson & Johnson Sued Over Sales Deal for Oral Cancer Product

According to Reuters, Johnson & Johnson is being sued by Oral Cancer Prevention International, claiming the drug manufacturer interfered with a sales agreement related to the distribution of an oral
Read More